Search Result - Primary Antibodies

  • anti-ZEB1 antibody
  • Cat. No: ARG43294  (Rabbit pAb)
  • Reactivity: Hu, Ms, Rat
  • Application: ICC/IF, IHC-P
  • Conjugation: Un-conjugated
  • anti-ZEB1 antibody
  • Cat. No: ARG64856  (Goat pAb)
  • Reactivity: Ms
  • Application: WB
  • Specificity: This antibody is expected to recognize both reported isoforms (NP_001121600.1; NP_110378.3).
  • Conjugation: Un-conjugated
  • anti-CD25 antibody [7D4]
  • Cat. No: ARG20879  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, IP, Neut, Depletion
  • Specificity: Mouse CD25. The clone 7D4 reacts with an epitope between amino acids 125 and 212 that is distinct from that recognized by The clone 3C7. While The clone 7D4 does not block the binding of IL-2 to CD25, when used in combination with The clone 3C7 it results in higher levels of inhibition of IL-2-driven proliferation than either of these two monoclonal antibodies alone.
  • Conjugation: Un-conjugated
  • anti-CD25 antibody [7D4] (PE-Cyanine 7)
  • Cat. No: ARG20886  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, Neut, Depletion
  • Specificity: Mouse CD25. The clone 7D4 reacts with an epitope between amino acids 125 and 212 that is distinct from that recognized by The clone 3C7. While The clone 7D4 does not block the binding of IL-2 to CD25, when used in combination with The clone 3C7 it results in higher levels of inhibition of IL-2-driven proliferation than either of these two monoclonal antibodies alone.
  • Conjugation: PE-Cyanine 7
  • anti-CD25 antibody [7D4] (Biotin)
  • Cat. No: ARG20881  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, Neut, Depletion
  • Specificity: Mouse CD25. The clone 7D4 reacts with an epitope between amino acids 125 and 212 that is distinct from that recognized by The clone 3C7. While The clone 7D4 does not block the binding of IL-2 to CD25, when used in combination with The clone 3C7 it results in higher levels of inhibition of IL-2-driven proliferation than either of these two monoclonal antibodies alone.
  • Conjugation: Biotin
  • anti-CD25 antibody [7D4] (PE)
  • Cat. No: ARG20882  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, Neut, Depletion
  • Specificity: Mouse CD25. The clone 7D4 reacts with an epitope between amino acids 125 and 212 that is distinct from that recognized by The clone 3C7. While The clone 7D4 does not block the binding of IL-2 to CD25, when used in combination with The clone 3C7 it results in higher levels of inhibition of IL-2-driven proliferation than either of these two monoclonal antibodies alone.
  • Conjugation: PE
  • anti-CD25 antibody [7D4] (APC)
  • Cat. No: ARG20883  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, Neut, Depletion
  • Specificity: Mouse CD25. The clone 7D4 reacts with an epitope between amino acids 125 and 212 that is distinct from that recognized by The clone 3C7. While The clone 7D4 does not block the binding of IL-2 to CD25, when used in combination with The clone 3C7 it results in higher levels of inhibition of IL-2-driven proliferation than either of these two monoclonal antibodies alone.
  • Conjugation: APC
  • anti-CD25 antibody [7D4] (PE-Cyanine 5)
  • Cat. No: ARG20884  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, Neut, Depletion
  • Specificity: Mouse CD25. The clone 7D4 reacts with an epitope between amino acids 125 and 212 that is distinct from that recognized by The clone 3C7. While The clone 7D4 does not block the binding of IL-2 to CD25, when used in combination with The clone 3C7 it results in higher levels of inhibition of IL-2-driven proliferation than either of these two monoclonal antibodies alone.
  • Conjugation: PE-Cyanine 5
  • anti-CD25 antibody [7D4] (low endotoxin)
  • Cat. No: ARG20885  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, IP, Neut, Depletion
  • Specificity: Mouse CD25. The clone 7D4 reacts with an epitope between amino acids 125 and 212 that is distinct from that recognized by The clone 3C7. While The clone 7D4 does not block the binding of IL-2 to CD25, when used in combination with The clone 3C7 it results in higher levels of inhibition of IL-2-driven proliferation than either of these two monoclonal antibodies alone.
  • Conjugation: Un-conjugated